NK Cells Respond to Checkpoint Blockade
- PMID: 30352860
- DOI: 10.1158/2159-8290.CD-NB2018-131
NK Cells Respond to Checkpoint Blockade
Abstract
A recent study suggests that natural killer (NK) cells may play an important role in antitumor response to immune checkpoint inhibitors. Researchers used mouse models to show that NK cells respond to PD-1 and PD-L1 inhibitors, information that could be used to develop immunotherapies that tap NK cells to combat cancer.
©2018 American Association for Cancer Research.
Comment on
-
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10. J Clin Invest. 2018. PMID: 30198904 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous